Methamphetamine Drug
Paper Details
Methamphetamine Drug
Abstract
Mesamphetamine is the scourge of the age and the most severe type of drugs, and it is also called the killer methamphetamine, shapo or glass ice. This drug is called a killer because it has great damage to the human body and all its organs that sometimes lead to death even if it was used for a short period of time. It is a crystalline drug distinguished by its white and blue color. Its abusers have often made addicts since the first use because it alters the dopamine and serotonin levels of the brain by increasing the doses which makes it permanent and irreversible damage, this reflects the speed of methamphetamine addiction. It allows the person to experience emotional feelings of depression or madness once it expires. This is why meth addicts are considered one of the most dangerous people due to the severe hallucinations this drug causes. Applying a treatment has nothing to do with pulmonary remodeling, it explains why Meth abuser always has an insufficiency of blood vessels and pulmonary arterial hypertension (PAH) all the time due to the chronic abuse of this substance. However, there are several treatments to help the abuser by reducing the symptoms, but applying it in a specific place may help its effectiveness and This facilitates the rehabilitation of the abuser easily.
Alhazmi HA, Ahsan W, AlbrattyM. 2020. Analysis of amphetamine and methamphetamine contents in seized tablets from Jazan, Saudi Arabia by liquid chromatography-mass spectroscopy (LC-MS/MS) and chemometric techniques. Saudi Pharmaceutical Journal 28(6), 703-709.
Al-Zubaidi M, Stuart A, Jayaratne T, Marsdin E. 2020. Non-surgical management of methamphetamine induced testicular ischemia. Urology Case Reports 32, 101238.
Baladi MG, Newman AH, Nielsen SM, Hanson GR, Fleckenstein AE. 2014. opamine D3 receptors contribute to methamphetamine-induced alteration in dopaminergic neuronal function: Role of hyperthermia. European Journal of Pharmacology 732, 105–110.
Brown PL, Wise RA, Kiyatkin EA. 2003. Brain Hyperthermia Is Induced by Methamphetamine and Exacerbated by Social Interaction. The Journal of Neuroscience 23, 3924 –3929.
Daniulaityte R, Silverstein SM, GetzK, Juhascik M, McElhinny M, Dudley S. 2022. Lay knowledge and practices of methamphetamine use to manage opioid-related verdose risks. International Journal of Drug Policy 99, 103-463.
Doyle JR, Yamamoto BK. 2010. Serotonin 2 receptor modulation of hyperthermia, corticosterone, and hippocampal serotonin depletions following serial exposure to chronic stress and methamphetamine. Psychoneuroendocrinology 35, 629-633.
García-Cabrerizo R, Bis-Humbert C, García-Fuster MJ. 2021. Electroconvulsive seizures protect against methamphetamine-induced inhibition of neurogenesis in the rat hippocampus. Neurotoxicology 86, 185-191.
Glick SN, Burt R, Kummer K, Tinsley J, Banta-green CJ, Golden MR. 2018. Increasing methamphetamine injection among non-MSM who inject drugs in King County, Washington. Drug and Alcohol Dependence 182, 86-92.
Haight WL, Carter-Black JD, Sheridan K. 2009. Mothers’ experience of methamphetamine addiction: A case-based analysis of rural, midwestern women 31(1), 71-77.
Halpin LE, Gunning WT, Yamamoto BK. 2013. Methamphetamine causes acute hyperthermia-dependent liver damage. Pharmacology Research and Perspectives 1, 1-11.
Huang Y, Chundury RV, Timperley BD, Terp PA, Krueger RR, Yeh S. 2022. Ophthalmic complications associated with methamphetamine use disorder. American Journal of Ophthalmology Case Reports 26, 101464.
Johnson-Davis KL, Fleckenstein AE, Wilkins DG. 2003. The role of hyperthermia and metabolism as mechanisms of tolerance to methamphetamine neurotoxicity. European Journal of Pharmacology 482, 151–154.
Kim K, Kim H, Li J, Kwon YB. 2011. Effect of bee venom acupuncture on methamphetamine-induced hyperactivity, hyperthermia and Fos expression in mice. Brain Research Bulletin 84, 61–68.
Kolaitis NA, Zamanian RT, de Jesus Perez AV. 2020. Clinical Differences and Outcomes between Methamphetamine-associated and Idiopathic Pulmonary Arterial Hypertension in the Pulmonary Hypertension Association Registry. ATS Journal 18, 613–622.
Kuperman DI, Freyaldenhoven TE, Schmued LC, Ali SF. 1997. Methamphetamine-induced hyperthermia in mice: examination of dopamine depletion and heat-shock protein induction. Brain Research 771, 221-227.
Labazi H, Nilsen M, MacLean MR. 2021. Sex-dependent right ventricular hypertrophic gene changes after methamphetamine treatment in mice. European Journal of Pharmacology 900, 174-066.
Lianga L, Wang M, Liuc M. 2020. Chronic toxicity of methamphetamine: Oxidative remodeling of pulmonary arteries. Toxicology in Vitro 62, 104-668.
Liu M, Wang W, Wang H. 2013. Fluoxetine Attenuates Chronic Methamphetamine-induced Pulmonary Arterial Remodelling: Possible Involvement of Serotonin Transporter and Serotonin 1B Receptor. Basic Clinical Pharmacology and Toxicology 112(2), 77-82.
Madden LJ, Flynn CT, Zandonatti MA. 2005. Modeling Human Methamphetamine Exposure in Nonhuman Primates: Chronic Dosing in the Rhesus Macaque Leads to Behavioral and Physiological Abnormalities. Neuropsychopharmacology 30, 350-359.
Mclntyre IM, Hamm C, Bader E. 2011. Postmortem Methamphetamine Distribution. McIntyre Journal Forensic Research 2(3), 1000122.
Segawa T, Ogasawara AY, Hasegawa N. 2019. Hypertensive heart disease associated with methamphetamine abuse. Journal of Cardiology Cases 19(2), 47-50.
Silverstein SM, Daniulaityte R, Kylie Getz W. 2021. It’s Crazy What Meth Can Help You Do: Lay Beliefs, Practices, and Experiences of Using Methamphetamine to Self-Treat Symptoms of Opioid Withdrawal. Substance Use and Misuse 56, 1687-1696.
Srisurapanont M, Arunpongpaisal S, Wada K, Marsden J, Ail R, Kongsakon R. 2011. Comparisons of methamphetamine psychotic and schizophrenic symptoms: A differential item functioning analysis. Progress in Neuro-Psychopharmacology and Biological Psychiatry 35 (4), 959-964.
Supiyani AH, Sugita P, Nainggolan I. 2022. Preparation sodium silicate from rice husk to synthesize silica nanoparticles by sol-gel method for adsorption water in analysis of methamphetamine. South African Journal of Chemical Engineering 40, 80-86.
Tian Y, Wang D, Fan F. 2022. Differences in cognitive deficits in patients with methamphetamine and heroin use disorder compared with healthy controls in a Chinese Han population. Progress in Neuro-Psychopharmacology and Biological Psychiatry 117, 110543.
Tsai H, Lee J, Hedlin H, Zamanian RT, de Jesus Perez VA. 2019. Methamphetamine use association with pulmonary diseases: a retrospective investigation of hospital discharges in California from 2005 to 2011. ERJ Open Research 5(4), 00017.
Wang X, Tong B, Hui R. 2021. The Role of Hyperthermia in Methamphetamine-Induced Depression-Like Behaviors: Protective Effects of Coral Calcium Hydride. Frontiers in Molecular Neuroscience 14, 808-807.
Winslow BT, Voorhees KI, Pehl KA. 2007, Methamphetamine Abuse. American Family Physician 76(8), 1169-1174.
Zamanian RT, Hedlin H, Greuenwald P. 2018. Features and Outcomes of Methamphetamine-associated Pulmonary Arterial Hypertension. American Journal Respiratory Critical Care Medicine 197, 788-800.
Zhao SX, Kwong C, Swaminathan A, Gohil H, Crawford MH. 2018. Clinical Characteristics and Outcome of Methamphetamine-Associated Pulmonary. Arterial Hypertension and Dilated Cardiomyopathy JACC: Heart Failure 6, 209-218.
Zibbell JE, Clarke SD, Kral AH, Richardson NJ, Cauchon D, Aldridge A. 2022. Association between law enforcement seizures of illicit drugs and drug overdose deaths involving cocaine and methamphetamine, Ohio, 2014–2019. Drug and Alcohol Dependence 232, 109341.
Rahaf A. Shawamiyan, Reema Almoallim, Haddad A. El Rabey (2022), Methamphetamine Drug; IJB, V20, N5, May, P148-161
https://innspub.net/methamphetamine-drug/
Copyright © 2022
By Authors and International
Network for Natural Sciences
(INNSPUB) https://innspub.net
This article is published under the terms of the
Creative Commons Attribution License 4.0